4-Pyrimidinecarboxamide, N-[(4-fluorophenyl-2,3,5,6-d4)methyl-d2]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-
| 中文名称 | 4-Pyrimidinecarboxamide, N-[(4-fluorophenyl-2,3,5,6-d4)methyl-d2]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo- |
|---|---|
| 中文同义词 | [2H6]-雷特格韦;雷特格韦-[D6];2H6]-拉替拉韦;雷特格韦-[d6] (标准品) |
| 英文名称 | 4-Pyrimidinecarboxamide, N-[(4-fluorophenyl-2,3,5,6-d4)methyl-d2]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo- |
| 英文同义词 | 4-Pyrimidinecarboxamide, N-[(4-fluorophenyl-2,3,5,6-d4)methyl-d2]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-;Raltegravir-[D6] (Standard) |
| CAS号 | 1100750-98-8 |
| 分子式 | C20H15D6FN6O5 |
| 分子量 | 450.453313868 |
| EINECS号 | |
| 相关类别 | |
| Mol文件 | 1100750-98-8.mol |
| 结构式 | ![4-Pyrimidinecarboxamide, N-[(4-fluorophenyl-2,3,5,6-d4)methyl-d2]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo- 结构式](CAS/20200401/GIF/1100750-98-8.gif) |
4-Pyrimidinecarboxamide, N-[(4-fluorophenyl-2,3,5,6-d4)methyl-d2]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo- 性质
4-Pyrimidinecarboxamide, N-[(4-fluorophenyl-2,3,5,6-d4)methyl-d2]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo- 用途与合成方法
Raltegravir-d6是氘代标记的Raltegravir。Raltegravir(MK0518)是HIV整合酶（IN）抑制剂。